Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04160533

Registry of Arterial Hypertension

The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population.

The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations.

The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice.

Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Federal State Budgetary Institution "National Medical Research Center of Cardiology named after academician E.I. Chazov" of the Ministry of Healthcare of the Russian Federation, Moscow, Moscow Oblast, Russia

Loading trial locations.

About this study

The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The diagnosis of arterial hypertension -

Exclusion criteria

No diagnosis of arterial hypertension

-

Treatment and study plan

Primary outcomes

  1. Number of patients with blood pressure <140/90 mm Hg

    Time frame: 2018 - 2021 years

    The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.

Secondary outcomes

  1. Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.

    Time frame: 2018-2021

    Diagnosis data is entered by doctors as a "yes" or "no" category.

  2. Antihypertensive medications

    Time frame: 2018-2021

    Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages

Study contacts

Contact information is provided by the study sponsor or research team.

Anna Aksenova, MD

CONTACT

[email protected]

+74954146186

Sponsors and collaborators

Lead sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Other Gov

Registry information

Official study title

Registry of Arterial Hypertension: "Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment"

Important dates

Study start
2018
Primary completion
2026
Study completion
2026
First posted
Nov 13, 2019
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.